Whitehawk Therapeutics Inc (WHWK)

$3.12 +0.12 (4.00%)
Market Cap 141.38M
Revenue (ttm) 25.98M
Net Income (ttm) -63.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -245.15%
Debt to Equity Ratio 0.00
Volume 85,600
Avg Vol 123,680
Day's Range N/A - N/A
Shares Out 47.13M
Stochastic %K 85%
Beta 0.59
Analysts Sell
Price Target $5.00

Company Profile

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Industry: Biotechnology
Sector: Healthcare
Phone: 551 321 2234
Address:
2 Headquarters Plaza, East Building 11th Floor, Morristown, United States
jnc1631
jnc1631 Feb. 24 at 5:24 PM
$WHWK not sure why we are trending up but not complaining, is it due to beta?
0 · Reply
TapeHunter
TapeHunter Feb. 18 at 10:13 AM
$WHWK Event-driven equity where catalysts are infrequent.
0 · Reply
PortfolioRealm
PortfolioRealm Feb. 17 at 2:32 PM
$WHWK Obscure micro-cap; minimal public information.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 13 at 12:20 AM
$WHWK RSI: 67.03, MACD: 0.0679 Vol: 0.09, MA20: 2.80, MA50: 2.63 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 8:37 PM
$WHWK
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 8:37 PM
$WHWK
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 7:47 PM
$WHWK
0 · Reply
Jarvis7424
Jarvis7424 Feb. 12 at 6:17 PM
$WHWK break $3
0 · Reply
optionravi
optionravi Feb. 10 at 12:36 PM
$WHWK is a biotech or pharmaceutical company; name not standard, indicating high risk and low visibility.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 20 at 9:24 AM
$WHWK Current Stock Price: $2.92 Contracts to trade: $2.5 WHWK Feb 20 2026 Call Entry: $0.97 Exit: $1.37 ROI: 41% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on WHWK
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 18, 2026, 8:00 AM EST - 6 days ago

Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

Jan 8, 2026, 8:00 AM EST - 6 weeks ago

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Dec 1, 2025, 8:00 AM EST - 3 months ago

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 26, 2025, 8:00 AM EST - 3 months ago

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Nov 11, 2025, 8:00 AM EST - 3 months ago

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Nov 6, 2025, 8:00 AM EST - 3 months ago

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Oct 24, 2025, 12:30 PM EDT - 4 months ago

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Oct 16, 2025, 8:30 AM EDT - 4 months ago

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

TEM

Whitehawk Therapeutics, Inc. (WHWK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 6:44 PM EDT - 6 months ago

Whitehawk Therapeutics, Inc. (WHWK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Sep 2, 2025, 8:00 AM EDT - 6 months ago

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Aug 7, 2025, 8:00 AM EDT - 7 months ago

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Jul 22, 2025, 8:00 AM EDT - 7 months ago

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

Jun 19, 2025, 8:00 AM EDT - 8 months ago

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 9 months ago

Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit

May 21, 2025, 8:00 AM EDT - 9 months ago

Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

May 8, 2025, 4:05 PM EDT - 10 months ago

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Mar 26, 2025, 8:00 AM EDT - 11 months ago

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:52 AM EDT - 1 year ago

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

Mar 18, 2025, 4:00 PM EDT - 1 year ago

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

jnc1631
jnc1631 Feb. 24 at 5:24 PM
$WHWK not sure why we are trending up but not complaining, is it due to beta?
0 · Reply
TapeHunter
TapeHunter Feb. 18 at 10:13 AM
$WHWK Event-driven equity where catalysts are infrequent.
0 · Reply
PortfolioRealm
PortfolioRealm Feb. 17 at 2:32 PM
$WHWK Obscure micro-cap; minimal public information.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 13 at 12:20 AM
$WHWK RSI: 67.03, MACD: 0.0679 Vol: 0.09, MA20: 2.80, MA50: 2.63 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 8:37 PM
$WHWK
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 8:37 PM
$WHWK
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 7:47 PM
$WHWK
0 · Reply
Jarvis7424
Jarvis7424 Feb. 12 at 6:17 PM
$WHWK break $3
0 · Reply
optionravi
optionravi Feb. 10 at 12:36 PM
$WHWK is a biotech or pharmaceutical company; name not standard, indicating high risk and low visibility.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 20 at 9:24 AM
$WHWK Current Stock Price: $2.92 Contracts to trade: $2.5 WHWK Feb 20 2026 Call Entry: $0.97 Exit: $1.37 ROI: 41% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Jarvis7424
Jarvis7424 Jan. 16 at 6:05 PM
$WHWK slow crawl back to $5+
0 · Reply
JonCollins
JonCollins Jan. 14 at 8:30 PM
$WHWK showing reversal signs on low volume.
0 · Reply
Jarvis7424
Jarvis7424 Jan. 14 at 6:23 PM
$WHWK cmon $3
0 · Reply
kshonstocks
kshonstocks Jan. 13 at 8:52 PM
$WHWK hitting scans good pattern
0 · Reply
jnc1631
jnc1631 Jan. 8 at 8:37 PM
$WHWK OK good. Now we wait another year… Then those results would be crucial for another capital raise and by then money hopefully is easier
0 · Reply
Jarvis7424
Jarvis7424 Jan. 8 at 2:29 PM
$WHWK IND submitted mid December! Looking forward to first data read out
0 · Reply
War_Admiral
War_Admiral Jan. 5 at 4:36 PM
$WHWK how do we grow as a company? Make and keep your promises... Where is the IND??
0 · Reply
30DeltaSpy
30DeltaSpy Jan. 4 at 4:07 PM
$WHWK bullish
0 · Reply
BrownianMotionB
BrownianMotionB Dec. 26 at 3:50 PM
$WHWK Risk appetite is present but conditioned on validation. Efficiency initiatives must translate into measurable productivity. Demonstrated durability would lengthen investor time horizons. The forward path ultimately depends on disciplined delivery.
0 · Reply
KDoc88
KDoc88 Dec. 24 at 3:21 PM
$WHWK
0 · Reply
KDoc88
KDoc88 Dec. 24 at 3:04 PM
$WHWK that volume can keep rolling!!
0 · Reply
KDoc88
KDoc88 Dec. 24 at 2:58 PM
$WHWK on the move!!!
0 · Reply